astx727
Showing 1 - 10 of 10
Acute Myeloid Leukemia Trial in Houston (ASTX727, ASTX029-01)
Not yet recruiting
- Acute Myeloid Leukemia
- ASTX727
- ASTX029-01
-
Houston, TexasMD Anderson Cancer Center
Oct 27, 2023
Acute Myeloid Leukemia Trial in Houston (SNDX-5613, Venetoclax, ASTX727)
Recruiting
- Acute Myeloid Leukemia
- SNDX-5613
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 14, 2022
Lower-risk Myelodysplastic Trial in Tokyo (ASTX727)
Active, not recruiting
- Lower-risk Myelodysplastic
- ASTX727
-
Tokyo, JapanNTT Medical Center Tokyo
Jan 14, 2022
Malignant Peripheral Nerve Sheath Tumors (MPNST) Trial in United States (ASTX727)
Recruiting
- Malignant Peripheral Nerve Sheath Tumors (MPNST)
- ASTX727
-
Basking Ridge, New Jersey
- +6 more
Aug 25, 2022
MDS, AML Trial in France (ASTX727, Donor Lymphocyte Infusions)
Recruiting
- MDS
- AML
- ASTX727
- Donor Lymphocyte Infusions
-
Amiens, France
- +15 more
Jul 21, 2022
Metastatic Breast Cancer, Triple Negative Breast Cancer, Hormone Receptor Positive Tumor Trial in Indianapolis, Winston-Salem
Recruiting
- Metastatic Breast Cancer
- +2 more
- Talazoparib
- ASTX727
-
Indianapolis, Indiana
- +1 more
Sep 28, 2021
Acute Myeloid Leukemia Trial in United States (ASTX660, ASTX727)
Active, not recruiting
- Acute Myeloid Leukemia
- ASTX660
- ASTX727
-
San Francisco, California
- +14 more
Jan 24, 2022
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Canada, United States (ASTX727)
Enrolling by invitation
- Acute Myeloid Leukemia
- +2 more
- ASTX727
-
Fountain Valley, California
- +28 more
Nov 18, 2022
MDS/MPN Trial in Nashville (ASTX727, Itacitinib)
Recruiting
- MDS/MPN
- ASTX727
- Itacitinib
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Jun 20, 2022
Neurological Cancer Trial in Boston (ASTX727)
Recruiting
- Neurological Cancer
- ASTX727
-
Boston, Massachusetts
- +2 more
Sep 5, 2020